日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer.

RNF112 促进泛素介导的 c-Myc 降解,抑制膀胱癌细胞的增殖、迁移和脂质合成

Xiong Kangping, Chen Siming, Xu Huimin, Tu Sheng, Weng Hong, Wang Yejinpeng, Li Mingxing, Yu Jingtian, Qian Kaiyu, Ju Lingao, Zhang Yi, Xiao Yu, Wang Xinghuan, Wang Gang

Pedigree analysis of a POLD1 germline mutation in urothelial carcinoma shows a close association between different mutation burdens and overall survival

对尿路上皮癌中 POLD1 生殖系突变的家系分析显示,不同的突变负荷与总生存期密切相关。

Wang, Yejinpeng; Ju, Lingao; Guo, Zicheng; Qian, Kaiyu; Chen, Hongbo; Zhang, Yi; Xiao, Yu; Wang, Xinghuan

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer

膀胱癌六基因预后特征的开发与验证

Xu, Fei; Tang, Qianqian; Wang, Yejinpeng; Wang, Gang; Qian, Kaiyu; Ju, Lingao; Xiao, Yu

Comprehensive genomic profiling of urothelial carcinoma cell lines reveals hidden research bias and caveats

对尿路上皮癌细胞系进行全面的基因组分析揭示了隐藏的研究偏差和局限性

Luo, Yongwen; Ju, Lingao; Wang, Gang; Chen, Chen; Wang, Yejinpeng; Chen, Liang; Zhang, Yi; Xiao, Yu; Wang, Xinghuan

Epigenetic signature predicts overall survival clear cell renal cell carcinoma

表观遗传特征预测透明细胞肾细胞癌患者的总体生存率

Wang, Yejinpeng; Chen, Liang; Ju, Lingao; Qian, Kaiyu; Wang, Xinghuan; Xiao, Yu; Wang, Gang

Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer

免疫相关特征可预测膀胱癌的预后和免疫治疗获益

Wang, Yejinpeng; Chen, Liang; Yu, Mengxue; Fang, Yayun; Qian, Kaiyu; Wang, Gang; Ju, Lingao; Xiao, Yu; Wang, Xinghuan

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma

建立T1G3期膀胱尿路上皮癌复发和进展的预测模型

Chen, Song; Lu, Mengxin; Peng, Tianchen; Wang, Yejinpeng; Liu, Xuefeng; Xiao, Yu; Wang, Xinghuan